Cargando…
Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer
BACKGROUND: Gastrointestinal cancer poses a serious health threat owing to its high morbidity and mortality. Although immune checkpoint blockade (ICB) therapies have achieved meaningful success in most solid tumors, the improvement in survival in gastrointestinal cancers is modest, owing to sparse i...
Autores principales: | Wang, Xiangwen, Zhou, Liwen, Wang, Hongpeng, Chen, Wei, Jiang, Lei, Ming, Guangtao, Wang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660574/ https://www.ncbi.nlm.nih.gov/pubmed/37860928 http://dx.doi.org/10.1002/cam4.6623 |
Ejemplares similares
-
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
por: Gao, Weitong, et al.
Publicado: (2022) -
ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity
por: Gan, Boyi
Publicado: (2022) -
Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies
por: Shi, Tao, et al.
Publicado: (2023) -
Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
por: You, Gihoon, et al.
Publicado: (2021) -
PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma
por: Hu, Xiaomeng, et al.
Publicado: (2022)